QTTB
Q32 Bio Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.99
−6.33%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.36
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.44
- EPS estimate
- -$0.46
- Revenue actual
- —
- Revenue estimate
- $750.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +145.4%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $44
- PT range
- $34 – $66
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026